Medical Care
Global Liposomal Drug Delivery Device Market Research Report 2025
- Mar 11, 25
- ID: 77649
- Pages: 82
- Figures: 83
- Views: 20
The global market for Liposomal Drug Delivery Device was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Liposomal Drug Delivery Device, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Liposomal Drug Delivery Device.
The Liposomal Drug Delivery Device market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Liposomal Drug Delivery Device market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Liposomal Drug Delivery Device companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Novartis AG
Luye Pharma Group
Ipsen Pharma
Celsion, Inc.
Galen Limited
Astellas Pharma, Inc.
Acrotech Biopharma, Inc.
Fudan-Zhangjiang
Pacira
Creative Biolabs
Precision NanoSystems Inc.
Encapsula NanoSciences LLC
Avanti Polar Lipids, Inc.
Viatris Inc.
Merrimack Pharmaceuticals, Inc
Segment by Type
Stealth Liposome Technology
NonPEGylated Liposome Technology
DepoFoam Liposome Technology
Segment by Application
Fungal Diseases
Cancer Therapy
Pain Management
Viral Vaccines
Photodynamic Therapy
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Liposomal Drug Delivery Device company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Liposomal Drug Delivery Device, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Liposomal Drug Delivery Device.
The Liposomal Drug Delivery Device market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Liposomal Drug Delivery Device market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Liposomal Drug Delivery Device companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Novartis AG
Luye Pharma Group
Ipsen Pharma
Celsion, Inc.
Galen Limited
Astellas Pharma, Inc.
Acrotech Biopharma, Inc.
Fudan-Zhangjiang
Pacira
Creative Biolabs
Precision NanoSystems Inc.
Encapsula NanoSciences LLC
Avanti Polar Lipids, Inc.
Viatris Inc.
Merrimack Pharmaceuticals, Inc
Segment by Type
Stealth Liposome Technology
NonPEGylated Liposome Technology
DepoFoam Liposome Technology
Segment by Application
Fungal Diseases
Cancer Therapy
Pain Management
Viral Vaccines
Photodynamic Therapy
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Liposomal Drug Delivery Device company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Liposomal Drug Delivery Device Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Stealth Liposome Technology
1.2.3 NonPEGylated Liposome Technology
1.2.4 DepoFoam Liposome Technology
1.3 Market by Application
1.3.1 Global Liposomal Drug Delivery Device Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Fungal Diseases
1.3.3 Cancer Therapy
1.3.4 Pain Management
1.3.5 Viral Vaccines
1.3.6 Photodynamic Therapy
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Liposomal Drug Delivery Device Market Perspective (2020-2031)
2.2 Global Liposomal Drug Delivery Device Growth Trends by Region
2.2.1 Global Liposomal Drug Delivery Device Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Liposomal Drug Delivery Device Historic Market Size by Region (2020-2025)
2.2.3 Liposomal Drug Delivery Device Forecasted Market Size by Region (2026-2031)
2.3 Liposomal Drug Delivery Device Market Dynamics
2.3.1 Liposomal Drug Delivery Device Industry Trends
2.3.2 Liposomal Drug Delivery Device Market Drivers
2.3.3 Liposomal Drug Delivery Device Market Challenges
2.3.4 Liposomal Drug Delivery Device Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Liposomal Drug Delivery Device Players by Revenue
3.1.1 Global Top Liposomal Drug Delivery Device Players by Revenue (2020-2025)
3.1.2 Global Liposomal Drug Delivery Device Revenue Market Share by Players (2020-2025)
3.2 Global Liposomal Drug Delivery Device Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Liposomal Drug Delivery Device Revenue
3.4 Global Liposomal Drug Delivery Device Market Concentration Ratio
3.4.1 Global Liposomal Drug Delivery Device Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Liposomal Drug Delivery Device Revenue in 2024
3.5 Global Key Players of Liposomal Drug Delivery Device Head office and Area Served
3.6 Global Key Players of Liposomal Drug Delivery Device, Product and Application
3.7 Global Key Players of Liposomal Drug Delivery Device, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Liposomal Drug Delivery Device Breakdown Data by Type
4.1 Global Liposomal Drug Delivery Device Historic Market Size by Type (2020-2025)
4.2 Global Liposomal Drug Delivery Device Forecasted Market Size by Type (2026-2031)
5 Liposomal Drug Delivery Device Breakdown Data by Application
5.1 Global Liposomal Drug Delivery Device Historic Market Size by Application (2020-2025)
5.2 Global Liposomal Drug Delivery Device Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Liposomal Drug Delivery Device Market Size (2020-2031)
6.2 North America Liposomal Drug Delivery Device Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Liposomal Drug Delivery Device Market Size by Country (2020-2025)
6.4 North America Liposomal Drug Delivery Device Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Liposomal Drug Delivery Device Market Size (2020-2031)
7.2 Europe Liposomal Drug Delivery Device Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Liposomal Drug Delivery Device Market Size by Country (2020-2025)
7.4 Europe Liposomal Drug Delivery Device Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Liposomal Drug Delivery Device Market Size (2020-2031)
8.2 Asia-Pacific Liposomal Drug Delivery Device Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Liposomal Drug Delivery Device Market Size by Region (2020-2025)
8.4 Asia-Pacific Liposomal Drug Delivery Device Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Liposomal Drug Delivery Device Market Size (2020-2031)
9.2 Latin America Liposomal Drug Delivery Device Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Liposomal Drug Delivery Device Market Size by Country (2020-2025)
9.4 Latin America Liposomal Drug Delivery Device Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Liposomal Drug Delivery Device Market Size (2020-2031)
10.2 Middle East & Africa Liposomal Drug Delivery Device Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Liposomal Drug Delivery Device Market Size by Country (2020-2025)
10.4 Middle East & Africa Liposomal Drug Delivery Device Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Novartis AG
11.1.1 Novartis AG Company Details
11.1.2 Novartis AG Business Overview
11.1.3 Novartis AG Liposomal Drug Delivery Device Introduction
11.1.4 Novartis AG Revenue in Liposomal Drug Delivery Device Business (2020-2025)
11.1.5 Novartis AG Recent Development
11.2 Luye Pharma Group
11.2.1 Luye Pharma Group Company Details
11.2.2 Luye Pharma Group Business Overview
11.2.3 Luye Pharma Group Liposomal Drug Delivery Device Introduction
11.2.4 Luye Pharma Group Revenue in Liposomal Drug Delivery Device Business (2020-2025)
11.2.5 Luye Pharma Group Recent Development
11.3 Ipsen Pharma
11.3.1 Ipsen Pharma Company Details
11.3.2 Ipsen Pharma Business Overview
11.3.3 Ipsen Pharma Liposomal Drug Delivery Device Introduction
11.3.4 Ipsen Pharma Revenue in Liposomal Drug Delivery Device Business (2020-2025)
11.3.5 Ipsen Pharma Recent Development
11.4 Celsion, Inc.
11.4.1 Celsion, Inc. Company Details
11.4.2 Celsion, Inc. Business Overview
11.4.3 Celsion, Inc. Liposomal Drug Delivery Device Introduction
11.4.4 Celsion, Inc. Revenue in Liposomal Drug Delivery Device Business (2020-2025)
11.4.5 Celsion, Inc. Recent Development
11.5 Galen Limited
11.5.1 Galen Limited Company Details
11.5.2 Galen Limited Business Overview
11.5.3 Galen Limited Liposomal Drug Delivery Device Introduction
11.5.4 Galen Limited Revenue in Liposomal Drug Delivery Device Business (2020-2025)
11.5.5 Galen Limited Recent Development
11.6 Astellas Pharma, Inc.
11.6.1 Astellas Pharma, Inc. Company Details
11.6.2 Astellas Pharma, Inc. Business Overview
11.6.3 Astellas Pharma, Inc. Liposomal Drug Delivery Device Introduction
11.6.4 Astellas Pharma, Inc. Revenue in Liposomal Drug Delivery Device Business (2020-2025)
11.6.5 Astellas Pharma, Inc. Recent Development
11.7 Acrotech Biopharma, Inc.
11.7.1 Acrotech Biopharma, Inc. Company Details
11.7.2 Acrotech Biopharma, Inc. Business Overview
11.7.3 Acrotech Biopharma, Inc. Liposomal Drug Delivery Device Introduction
11.7.4 Acrotech Biopharma, Inc. Revenue in Liposomal Drug Delivery Device Business (2020-2025)
11.7.5 Acrotech Biopharma, Inc. Recent Development
11.8 Fudan-Zhangjiang
11.8.1 Fudan-Zhangjiang Company Details
11.8.2 Fudan-Zhangjiang Business Overview
11.8.3 Fudan-Zhangjiang Liposomal Drug Delivery Device Introduction
11.8.4 Fudan-Zhangjiang Revenue in Liposomal Drug Delivery Device Business (2020-2025)
11.8.5 Fudan-Zhangjiang Recent Development
11.9 Pacira
11.9.1 Pacira Company Details
11.9.2 Pacira Business Overview
11.9.3 Pacira Liposomal Drug Delivery Device Introduction
11.9.4 Pacira Revenue in Liposomal Drug Delivery Device Business (2020-2025)
11.9.5 Pacira Recent Development
11.10 Creative Biolabs
11.10.1 Creative Biolabs Company Details
11.10.2 Creative Biolabs Business Overview
11.10.3 Creative Biolabs Liposomal Drug Delivery Device Introduction
11.10.4 Creative Biolabs Revenue in Liposomal Drug Delivery Device Business (2020-2025)
11.10.5 Creative Biolabs Recent Development
11.11 Precision NanoSystems Inc.
11.11.1 Precision NanoSystems Inc. Company Details
11.11.2 Precision NanoSystems Inc. Business Overview
11.11.3 Precision NanoSystems Inc. Liposomal Drug Delivery Device Introduction
11.11.4 Precision NanoSystems Inc. Revenue in Liposomal Drug Delivery Device Business (2020-2025)
11.11.5 Precision NanoSystems Inc. Recent Development
11.12 Encapsula NanoSciences LLC
11.12.1 Encapsula NanoSciences LLC Company Details
11.12.2 Encapsula NanoSciences LLC Business Overview
11.12.3 Encapsula NanoSciences LLC Liposomal Drug Delivery Device Introduction
11.12.4 Encapsula NanoSciences LLC Revenue in Liposomal Drug Delivery Device Business (2020-2025)
11.12.5 Encapsula NanoSciences LLC Recent Development
11.13 Avanti Polar Lipids, Inc.
11.13.1 Avanti Polar Lipids, Inc. Company Details
11.13.2 Avanti Polar Lipids, Inc. Business Overview
11.13.3 Avanti Polar Lipids, Inc. Liposomal Drug Delivery Device Introduction
11.13.4 Avanti Polar Lipids, Inc. Revenue in Liposomal Drug Delivery Device Business (2020-2025)
11.13.5 Avanti Polar Lipids, Inc. Recent Development
11.14 Viatris Inc.
11.14.1 Viatris Inc. Company Details
11.14.2 Viatris Inc. Business Overview
11.14.3 Viatris Inc. Liposomal Drug Delivery Device Introduction
11.14.4 Viatris Inc. Revenue in Liposomal Drug Delivery Device Business (2020-2025)
11.14.5 Viatris Inc. Recent Development
11.15 Merrimack Pharmaceuticals, Inc
11.15.1 Merrimack Pharmaceuticals, Inc Company Details
11.15.2 Merrimack Pharmaceuticals, Inc Business Overview
11.15.3 Merrimack Pharmaceuticals, Inc Liposomal Drug Delivery Device Introduction
11.15.4 Merrimack Pharmaceuticals, Inc Revenue in Liposomal Drug Delivery Device Business (2020-2025)
11.15.5 Merrimack Pharmaceuticals, Inc Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Liposomal Drug Delivery Device Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Stealth Liposome Technology
1.2.3 NonPEGylated Liposome Technology
1.2.4 DepoFoam Liposome Technology
1.3 Market by Application
1.3.1 Global Liposomal Drug Delivery Device Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Fungal Diseases
1.3.3 Cancer Therapy
1.3.4 Pain Management
1.3.5 Viral Vaccines
1.3.6 Photodynamic Therapy
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Liposomal Drug Delivery Device Market Perspective (2020-2031)
2.2 Global Liposomal Drug Delivery Device Growth Trends by Region
2.2.1 Global Liposomal Drug Delivery Device Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Liposomal Drug Delivery Device Historic Market Size by Region (2020-2025)
2.2.3 Liposomal Drug Delivery Device Forecasted Market Size by Region (2026-2031)
2.3 Liposomal Drug Delivery Device Market Dynamics
2.3.1 Liposomal Drug Delivery Device Industry Trends
2.3.2 Liposomal Drug Delivery Device Market Drivers
2.3.3 Liposomal Drug Delivery Device Market Challenges
2.3.4 Liposomal Drug Delivery Device Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Liposomal Drug Delivery Device Players by Revenue
3.1.1 Global Top Liposomal Drug Delivery Device Players by Revenue (2020-2025)
3.1.2 Global Liposomal Drug Delivery Device Revenue Market Share by Players (2020-2025)
3.2 Global Liposomal Drug Delivery Device Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Liposomal Drug Delivery Device Revenue
3.4 Global Liposomal Drug Delivery Device Market Concentration Ratio
3.4.1 Global Liposomal Drug Delivery Device Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Liposomal Drug Delivery Device Revenue in 2024
3.5 Global Key Players of Liposomal Drug Delivery Device Head office and Area Served
3.6 Global Key Players of Liposomal Drug Delivery Device, Product and Application
3.7 Global Key Players of Liposomal Drug Delivery Device, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Liposomal Drug Delivery Device Breakdown Data by Type
4.1 Global Liposomal Drug Delivery Device Historic Market Size by Type (2020-2025)
4.2 Global Liposomal Drug Delivery Device Forecasted Market Size by Type (2026-2031)
5 Liposomal Drug Delivery Device Breakdown Data by Application
5.1 Global Liposomal Drug Delivery Device Historic Market Size by Application (2020-2025)
5.2 Global Liposomal Drug Delivery Device Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Liposomal Drug Delivery Device Market Size (2020-2031)
6.2 North America Liposomal Drug Delivery Device Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Liposomal Drug Delivery Device Market Size by Country (2020-2025)
6.4 North America Liposomal Drug Delivery Device Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Liposomal Drug Delivery Device Market Size (2020-2031)
7.2 Europe Liposomal Drug Delivery Device Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Liposomal Drug Delivery Device Market Size by Country (2020-2025)
7.4 Europe Liposomal Drug Delivery Device Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Liposomal Drug Delivery Device Market Size (2020-2031)
8.2 Asia-Pacific Liposomal Drug Delivery Device Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Liposomal Drug Delivery Device Market Size by Region (2020-2025)
8.4 Asia-Pacific Liposomal Drug Delivery Device Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Liposomal Drug Delivery Device Market Size (2020-2031)
9.2 Latin America Liposomal Drug Delivery Device Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Liposomal Drug Delivery Device Market Size by Country (2020-2025)
9.4 Latin America Liposomal Drug Delivery Device Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Liposomal Drug Delivery Device Market Size (2020-2031)
10.2 Middle East & Africa Liposomal Drug Delivery Device Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Liposomal Drug Delivery Device Market Size by Country (2020-2025)
10.4 Middle East & Africa Liposomal Drug Delivery Device Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Novartis AG
11.1.1 Novartis AG Company Details
11.1.2 Novartis AG Business Overview
11.1.3 Novartis AG Liposomal Drug Delivery Device Introduction
11.1.4 Novartis AG Revenue in Liposomal Drug Delivery Device Business (2020-2025)
11.1.5 Novartis AG Recent Development
11.2 Luye Pharma Group
11.2.1 Luye Pharma Group Company Details
11.2.2 Luye Pharma Group Business Overview
11.2.3 Luye Pharma Group Liposomal Drug Delivery Device Introduction
11.2.4 Luye Pharma Group Revenue in Liposomal Drug Delivery Device Business (2020-2025)
11.2.5 Luye Pharma Group Recent Development
11.3 Ipsen Pharma
11.3.1 Ipsen Pharma Company Details
11.3.2 Ipsen Pharma Business Overview
11.3.3 Ipsen Pharma Liposomal Drug Delivery Device Introduction
11.3.4 Ipsen Pharma Revenue in Liposomal Drug Delivery Device Business (2020-2025)
11.3.5 Ipsen Pharma Recent Development
11.4 Celsion, Inc.
11.4.1 Celsion, Inc. Company Details
11.4.2 Celsion, Inc. Business Overview
11.4.3 Celsion, Inc. Liposomal Drug Delivery Device Introduction
11.4.4 Celsion, Inc. Revenue in Liposomal Drug Delivery Device Business (2020-2025)
11.4.5 Celsion, Inc. Recent Development
11.5 Galen Limited
11.5.1 Galen Limited Company Details
11.5.2 Galen Limited Business Overview
11.5.3 Galen Limited Liposomal Drug Delivery Device Introduction
11.5.4 Galen Limited Revenue in Liposomal Drug Delivery Device Business (2020-2025)
11.5.5 Galen Limited Recent Development
11.6 Astellas Pharma, Inc.
11.6.1 Astellas Pharma, Inc. Company Details
11.6.2 Astellas Pharma, Inc. Business Overview
11.6.3 Astellas Pharma, Inc. Liposomal Drug Delivery Device Introduction
11.6.4 Astellas Pharma, Inc. Revenue in Liposomal Drug Delivery Device Business (2020-2025)
11.6.5 Astellas Pharma, Inc. Recent Development
11.7 Acrotech Biopharma, Inc.
11.7.1 Acrotech Biopharma, Inc. Company Details
11.7.2 Acrotech Biopharma, Inc. Business Overview
11.7.3 Acrotech Biopharma, Inc. Liposomal Drug Delivery Device Introduction
11.7.4 Acrotech Biopharma, Inc. Revenue in Liposomal Drug Delivery Device Business (2020-2025)
11.7.5 Acrotech Biopharma, Inc. Recent Development
11.8 Fudan-Zhangjiang
11.8.1 Fudan-Zhangjiang Company Details
11.8.2 Fudan-Zhangjiang Business Overview
11.8.3 Fudan-Zhangjiang Liposomal Drug Delivery Device Introduction
11.8.4 Fudan-Zhangjiang Revenue in Liposomal Drug Delivery Device Business (2020-2025)
11.8.5 Fudan-Zhangjiang Recent Development
11.9 Pacira
11.9.1 Pacira Company Details
11.9.2 Pacira Business Overview
11.9.3 Pacira Liposomal Drug Delivery Device Introduction
11.9.4 Pacira Revenue in Liposomal Drug Delivery Device Business (2020-2025)
11.9.5 Pacira Recent Development
11.10 Creative Biolabs
11.10.1 Creative Biolabs Company Details
11.10.2 Creative Biolabs Business Overview
11.10.3 Creative Biolabs Liposomal Drug Delivery Device Introduction
11.10.4 Creative Biolabs Revenue in Liposomal Drug Delivery Device Business (2020-2025)
11.10.5 Creative Biolabs Recent Development
11.11 Precision NanoSystems Inc.
11.11.1 Precision NanoSystems Inc. Company Details
11.11.2 Precision NanoSystems Inc. Business Overview
11.11.3 Precision NanoSystems Inc. Liposomal Drug Delivery Device Introduction
11.11.4 Precision NanoSystems Inc. Revenue in Liposomal Drug Delivery Device Business (2020-2025)
11.11.5 Precision NanoSystems Inc. Recent Development
11.12 Encapsula NanoSciences LLC
11.12.1 Encapsula NanoSciences LLC Company Details
11.12.2 Encapsula NanoSciences LLC Business Overview
11.12.3 Encapsula NanoSciences LLC Liposomal Drug Delivery Device Introduction
11.12.4 Encapsula NanoSciences LLC Revenue in Liposomal Drug Delivery Device Business (2020-2025)
11.12.5 Encapsula NanoSciences LLC Recent Development
11.13 Avanti Polar Lipids, Inc.
11.13.1 Avanti Polar Lipids, Inc. Company Details
11.13.2 Avanti Polar Lipids, Inc. Business Overview
11.13.3 Avanti Polar Lipids, Inc. Liposomal Drug Delivery Device Introduction
11.13.4 Avanti Polar Lipids, Inc. Revenue in Liposomal Drug Delivery Device Business (2020-2025)
11.13.5 Avanti Polar Lipids, Inc. Recent Development
11.14 Viatris Inc.
11.14.1 Viatris Inc. Company Details
11.14.2 Viatris Inc. Business Overview
11.14.3 Viatris Inc. Liposomal Drug Delivery Device Introduction
11.14.4 Viatris Inc. Revenue in Liposomal Drug Delivery Device Business (2020-2025)
11.14.5 Viatris Inc. Recent Development
11.15 Merrimack Pharmaceuticals, Inc
11.15.1 Merrimack Pharmaceuticals, Inc Company Details
11.15.2 Merrimack Pharmaceuticals, Inc Business Overview
11.15.3 Merrimack Pharmaceuticals, Inc Liposomal Drug Delivery Device Introduction
11.15.4 Merrimack Pharmaceuticals, Inc Revenue in Liposomal Drug Delivery Device Business (2020-2025)
11.15.5 Merrimack Pharmaceuticals, Inc Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Liposomal Drug Delivery Device Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Stealth Liposome Technology
Table 3. Key Players of NonPEGylated Liposome Technology
Table 4. Key Players of DepoFoam Liposome Technology
Table 5. Global Liposomal Drug Delivery Device Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Liposomal Drug Delivery Device Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Liposomal Drug Delivery Device Market Size by Region (2020-2025) & (US$ Million)
Table 8. Global Liposomal Drug Delivery Device Market Share by Region (2020-2025)
Table 9. Global Liposomal Drug Delivery Device Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 10. Global Liposomal Drug Delivery Device Market Share by Region (2026-2031)
Table 11. Liposomal Drug Delivery Device Market Trends
Table 12. Liposomal Drug Delivery Device Market Drivers
Table 13. Liposomal Drug Delivery Device Market Challenges
Table 14. Liposomal Drug Delivery Device Market Restraints
Table 15. Global Liposomal Drug Delivery Device Revenue by Players (2020-2025) & (US$ Million)
Table 16. Global Liposomal Drug Delivery Device Market Share by Players (2020-2025)
Table 17. Global Top Liposomal Drug Delivery Device Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Liposomal Drug Delivery Device as of 2024)
Table 18. Ranking of Global Top Liposomal Drug Delivery Device Companies by Revenue (US$ Million) in 2024
Table 19. Global 5 Largest Players Market Share by Liposomal Drug Delivery Device Revenue (CR5 and HHI) & (2020-2025)
Table 20. Global Key Players of Liposomal Drug Delivery Device, Headquarters and Area Served
Table 21. Global Key Players of Liposomal Drug Delivery Device, Product and Application
Table 22. Global Key Players of Liposomal Drug Delivery Device, Date of Enter into This Industry
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Liposomal Drug Delivery Device Market Size by Type (2020-2025) & (US$ Million)
Table 25. Global Liposomal Drug Delivery Device Revenue Market Share by Type (2020-2025)
Table 26. Global Liposomal Drug Delivery Device Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 27. Global Liposomal Drug Delivery Device Revenue Market Share by Type (2026-2031)
Table 28. Global Liposomal Drug Delivery Device Market Size by Application (2020-2025) & (US$ Million)
Table 29. Global Liposomal Drug Delivery Device Revenue Market Share by Application (2020-2025)
Table 30. Global Liposomal Drug Delivery Device Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 31. Global Liposomal Drug Delivery Device Revenue Market Share by Application (2026-2031)
Table 32. North America Liposomal Drug Delivery Device Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 33. North America Liposomal Drug Delivery Device Market Size by Country (2020-2025) & (US$ Million)
Table 34. North America Liposomal Drug Delivery Device Market Size by Country (2026-2031) & (US$ Million)
Table 35. Europe Liposomal Drug Delivery Device Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 36. Europe Liposomal Drug Delivery Device Market Size by Country (2020-2025) & (US$ Million)
Table 37. Europe Liposomal Drug Delivery Device Market Size by Country (2026-2031) & (US$ Million)
Table 38. Asia-Pacific Liposomal Drug Delivery Device Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 39. Asia-Pacific Liposomal Drug Delivery Device Market Size by Region (2020-2025) & (US$ Million)
Table 40. Asia-Pacific Liposomal Drug Delivery Device Market Size by Region (2026-2031) & (US$ Million)
Table 41. Latin America Liposomal Drug Delivery Device Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 42. Latin America Liposomal Drug Delivery Device Market Size by Country (2020-2025) & (US$ Million)
Table 43. Latin America Liposomal Drug Delivery Device Market Size by Country (2026-2031) & (US$ Million)
Table 44. Middle East & Africa Liposomal Drug Delivery Device Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 45. Middle East & Africa Liposomal Drug Delivery Device Market Size by Country (2020-2025) & (US$ Million)
Table 46. Middle East & Africa Liposomal Drug Delivery Device Market Size by Country (2026-2031) & (US$ Million)
Table 47. Novartis AG Company Details
Table 48. Novartis AG Business Overview
Table 49. Novartis AG Liposomal Drug Delivery Device Product
Table 50. Novartis AG Revenue in Liposomal Drug Delivery Device Business (2020-2025) & (US$ Million)
Table 51. Novartis AG Recent Development
Table 52. Luye Pharma Group Company Details
Table 53. Luye Pharma Group Business Overview
Table 54. Luye Pharma Group Liposomal Drug Delivery Device Product
Table 55. Luye Pharma Group Revenue in Liposomal Drug Delivery Device Business (2020-2025) & (US$ Million)
Table 56. Luye Pharma Group Recent Development
Table 57. Ipsen Pharma Company Details
Table 58. Ipsen Pharma Business Overview
Table 59. Ipsen Pharma Liposomal Drug Delivery Device Product
Table 60. Ipsen Pharma Revenue in Liposomal Drug Delivery Device Business (2020-2025) & (US$ Million)
Table 61. Ipsen Pharma Recent Development
Table 62. Celsion, Inc. Company Details
Table 63. Celsion, Inc. Business Overview
Table 64. Celsion, Inc. Liposomal Drug Delivery Device Product
Table 65. Celsion, Inc. Revenue in Liposomal Drug Delivery Device Business (2020-2025) & (US$ Million)
Table 66. Celsion, Inc. Recent Development
Table 67. Galen Limited Company Details
Table 68. Galen Limited Business Overview
Table 69. Galen Limited Liposomal Drug Delivery Device Product
Table 70. Galen Limited Revenue in Liposomal Drug Delivery Device Business (2020-2025) & (US$ Million)
Table 71. Galen Limited Recent Development
Table 72. Astellas Pharma, Inc. Company Details
Table 73. Astellas Pharma, Inc. Business Overview
Table 74. Astellas Pharma, Inc. Liposomal Drug Delivery Device Product
Table 75. Astellas Pharma, Inc. Revenue in Liposomal Drug Delivery Device Business (2020-2025) & (US$ Million)
Table 76. Astellas Pharma, Inc. Recent Development
Table 77. Acrotech Biopharma, Inc. Company Details
Table 78. Acrotech Biopharma, Inc. Business Overview
Table 79. Acrotech Biopharma, Inc. Liposomal Drug Delivery Device Product
Table 80. Acrotech Biopharma, Inc. Revenue in Liposomal Drug Delivery Device Business (2020-2025) & (US$ Million)
Table 81. Acrotech Biopharma, Inc. Recent Development
Table 82. Fudan-Zhangjiang Company Details
Table 83. Fudan-Zhangjiang Business Overview
Table 84. Fudan-Zhangjiang Liposomal Drug Delivery Device Product
Table 85. Fudan-Zhangjiang Revenue in Liposomal Drug Delivery Device Business (2020-2025) & (US$ Million)
Table 86. Fudan-Zhangjiang Recent Development
Table 87. Pacira Company Details
Table 88. Pacira Business Overview
Table 89. Pacira Liposomal Drug Delivery Device Product
Table 90. Pacira Revenue in Liposomal Drug Delivery Device Business (2020-2025) & (US$ Million)
Table 91. Pacira Recent Development
Table 92. Creative Biolabs Company Details
Table 93. Creative Biolabs Business Overview
Table 94. Creative Biolabs Liposomal Drug Delivery Device Product
Table 95. Creative Biolabs Revenue in Liposomal Drug Delivery Device Business (2020-2025) & (US$ Million)
Table 96. Creative Biolabs Recent Development
Table 97. Precision NanoSystems Inc. Company Details
Table 98. Precision NanoSystems Inc. Business Overview
Table 99. Precision NanoSystems Inc. Liposomal Drug Delivery Device Product
Table 100. Precision NanoSystems Inc. Revenue in Liposomal Drug Delivery Device Business (2020-2025) & (US$ Million)
Table 101. Precision NanoSystems Inc. Recent Development
Table 102. Encapsula NanoSciences LLC Company Details
Table 103. Encapsula NanoSciences LLC Business Overview
Table 104. Encapsula NanoSciences LLC Liposomal Drug Delivery Device Product
Table 105. Encapsula NanoSciences LLC Revenue in Liposomal Drug Delivery Device Business (2020-2025) & (US$ Million)
Table 106. Encapsula NanoSciences LLC Recent Development
Table 107. Avanti Polar Lipids, Inc. Company Details
Table 108. Avanti Polar Lipids, Inc. Business Overview
Table 109. Avanti Polar Lipids, Inc. Liposomal Drug Delivery Device Product
Table 110. Avanti Polar Lipids, Inc. Revenue in Liposomal Drug Delivery Device Business (2020-2025) & (US$ Million)
Table 111. Avanti Polar Lipids, Inc. Recent Development
Table 112. Viatris Inc. Company Details
Table 113. Viatris Inc. Business Overview
Table 114. Viatris Inc. Liposomal Drug Delivery Device Product
Table 115. Viatris Inc. Revenue in Liposomal Drug Delivery Device Business (2020-2025) & (US$ Million)
Table 116. Viatris Inc. Recent Development
Table 117. Merrimack Pharmaceuticals, Inc Company Details
Table 118. Merrimack Pharmaceuticals, Inc Business Overview
Table 119. Merrimack Pharmaceuticals, Inc Liposomal Drug Delivery Device Product
Table 120. Merrimack Pharmaceuticals, Inc Revenue in Liposomal Drug Delivery Device Business (2020-2025) & (US$ Million)
Table 121. Merrimack Pharmaceuticals, Inc Recent Development
Table 122. Research Programs/Design for This Report
Table 123. Key Data Information from Secondary Sources
Table 124. Key Data Information from Primary Sources
Table 125. Authors List of This Report
List of Figures
Figure 1. Liposomal Drug Delivery Device Picture
Figure 2. Global Liposomal Drug Delivery Device Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Liposomal Drug Delivery Device Market Share by Type: 2024 VS 2031
Figure 4. Stealth Liposome Technology Features
Figure 5. NonPEGylated Liposome Technology Features
Figure 6. DepoFoam Liposome Technology Features
Figure 7. Global Liposomal Drug Delivery Device Market Size by Application (2020-2031) & (US$ Million)
Figure 8. Global Liposomal Drug Delivery Device Market Share by Application: 2024 VS 2031
Figure 9. Fungal Diseases Case Studies
Figure 10. Cancer Therapy Case Studies
Figure 11. Pain Management Case Studies
Figure 12. Viral Vaccines Case Studies
Figure 13. Photodynamic Therapy Case Studies
Figure 14. Liposomal Drug Delivery Device Report Years Considered
Figure 15. Global Liposomal Drug Delivery Device Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 16. Global Liposomal Drug Delivery Device Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 17. Global Liposomal Drug Delivery Device Market Share by Region: 2024 VS 2031
Figure 18. Global Liposomal Drug Delivery Device Market Share by Players in 2024
Figure 19. Global Top Liposomal Drug Delivery Device Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Liposomal Drug Delivery Device as of 2024)
Figure 20. The Top 10 and 5 Players Market Share by Liposomal Drug Delivery Device Revenue in 2024
Figure 21. North America Liposomal Drug Delivery Device Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. North America Liposomal Drug Delivery Device Market Share by Country (2020-2031)
Figure 23. United States Liposomal Drug Delivery Device Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Canada Liposomal Drug Delivery Device Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe Liposomal Drug Delivery Device Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. Europe Liposomal Drug Delivery Device Market Share by Country (2020-2031)
Figure 27. Germany Liposomal Drug Delivery Device Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. France Liposomal Drug Delivery Device Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. U.K. Liposomal Drug Delivery Device Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Italy Liposomal Drug Delivery Device Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Russia Liposomal Drug Delivery Device Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Nordic Countries Liposomal Drug Delivery Device Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific Liposomal Drug Delivery Device Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Asia-Pacific Liposomal Drug Delivery Device Market Share by Region (2020-2031)
Figure 35. China Liposomal Drug Delivery Device Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Japan Liposomal Drug Delivery Device Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. South Korea Liposomal Drug Delivery Device Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Southeast Asia Liposomal Drug Delivery Device Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. India Liposomal Drug Delivery Device Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Australia Liposomal Drug Delivery Device Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America Liposomal Drug Delivery Device Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Latin America Liposomal Drug Delivery Device Market Share by Country (2020-2031)
Figure 43. Mexico Liposomal Drug Delivery Device Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Brazil Liposomal Drug Delivery Device Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa Liposomal Drug Delivery Device Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Middle East & Africa Liposomal Drug Delivery Device Market Share by Country (2020-2031)
Figure 47. Turkey Liposomal Drug Delivery Device Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Saudi Arabia Liposomal Drug Delivery Device Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. UAE Liposomal Drug Delivery Device Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 50. Novartis AG Revenue Growth Rate in Liposomal Drug Delivery Device Business (2020-2025)
Figure 51. Luye Pharma Group Revenue Growth Rate in Liposomal Drug Delivery Device Business (2020-2025)
Figure 52. Ipsen Pharma Revenue Growth Rate in Liposomal Drug Delivery Device Business (2020-2025)
Figure 53. Celsion, Inc. Revenue Growth Rate in Liposomal Drug Delivery Device Business (2020-2025)
Figure 54. Galen Limited Revenue Growth Rate in Liposomal Drug Delivery Device Business (2020-2025)
Figure 55. Astellas Pharma, Inc. Revenue Growth Rate in Liposomal Drug Delivery Device Business (2020-2025)
Figure 56. Acrotech Biopharma, Inc. Revenue Growth Rate in Liposomal Drug Delivery Device Business (2020-2025)
Figure 57. Fudan-Zhangjiang Revenue Growth Rate in Liposomal Drug Delivery Device Business (2020-2025)
Figure 58. Pacira Revenue Growth Rate in Liposomal Drug Delivery Device Business (2020-2025)
Figure 59. Creative Biolabs Revenue Growth Rate in Liposomal Drug Delivery Device Business (2020-2025)
Figure 60. Precision NanoSystems Inc. Revenue Growth Rate in Liposomal Drug Delivery Device Business (2020-2025)
Figure 61. Encapsula NanoSciences LLC Revenue Growth Rate in Liposomal Drug Delivery Device Business (2020-2025)
Figure 62. Avanti Polar Lipids, Inc. Revenue Growth Rate in Liposomal Drug Delivery Device Business (2020-2025)
Figure 63. Viatris Inc. Revenue Growth Rate in Liposomal Drug Delivery Device Business (2020-2025)
Figure 64. Merrimack Pharmaceuticals, Inc Revenue Growth Rate in Liposomal Drug Delivery Device Business (2020-2025)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
Table 1. Global Liposomal Drug Delivery Device Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Stealth Liposome Technology
Table 3. Key Players of NonPEGylated Liposome Technology
Table 4. Key Players of DepoFoam Liposome Technology
Table 5. Global Liposomal Drug Delivery Device Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Liposomal Drug Delivery Device Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Liposomal Drug Delivery Device Market Size by Region (2020-2025) & (US$ Million)
Table 8. Global Liposomal Drug Delivery Device Market Share by Region (2020-2025)
Table 9. Global Liposomal Drug Delivery Device Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 10. Global Liposomal Drug Delivery Device Market Share by Region (2026-2031)
Table 11. Liposomal Drug Delivery Device Market Trends
Table 12. Liposomal Drug Delivery Device Market Drivers
Table 13. Liposomal Drug Delivery Device Market Challenges
Table 14. Liposomal Drug Delivery Device Market Restraints
Table 15. Global Liposomal Drug Delivery Device Revenue by Players (2020-2025) & (US$ Million)
Table 16. Global Liposomal Drug Delivery Device Market Share by Players (2020-2025)
Table 17. Global Top Liposomal Drug Delivery Device Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Liposomal Drug Delivery Device as of 2024)
Table 18. Ranking of Global Top Liposomal Drug Delivery Device Companies by Revenue (US$ Million) in 2024
Table 19. Global 5 Largest Players Market Share by Liposomal Drug Delivery Device Revenue (CR5 and HHI) & (2020-2025)
Table 20. Global Key Players of Liposomal Drug Delivery Device, Headquarters and Area Served
Table 21. Global Key Players of Liposomal Drug Delivery Device, Product and Application
Table 22. Global Key Players of Liposomal Drug Delivery Device, Date of Enter into This Industry
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Liposomal Drug Delivery Device Market Size by Type (2020-2025) & (US$ Million)
Table 25. Global Liposomal Drug Delivery Device Revenue Market Share by Type (2020-2025)
Table 26. Global Liposomal Drug Delivery Device Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 27. Global Liposomal Drug Delivery Device Revenue Market Share by Type (2026-2031)
Table 28. Global Liposomal Drug Delivery Device Market Size by Application (2020-2025) & (US$ Million)
Table 29. Global Liposomal Drug Delivery Device Revenue Market Share by Application (2020-2025)
Table 30. Global Liposomal Drug Delivery Device Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 31. Global Liposomal Drug Delivery Device Revenue Market Share by Application (2026-2031)
Table 32. North America Liposomal Drug Delivery Device Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 33. North America Liposomal Drug Delivery Device Market Size by Country (2020-2025) & (US$ Million)
Table 34. North America Liposomal Drug Delivery Device Market Size by Country (2026-2031) & (US$ Million)
Table 35. Europe Liposomal Drug Delivery Device Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 36. Europe Liposomal Drug Delivery Device Market Size by Country (2020-2025) & (US$ Million)
Table 37. Europe Liposomal Drug Delivery Device Market Size by Country (2026-2031) & (US$ Million)
Table 38. Asia-Pacific Liposomal Drug Delivery Device Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 39. Asia-Pacific Liposomal Drug Delivery Device Market Size by Region (2020-2025) & (US$ Million)
Table 40. Asia-Pacific Liposomal Drug Delivery Device Market Size by Region (2026-2031) & (US$ Million)
Table 41. Latin America Liposomal Drug Delivery Device Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 42. Latin America Liposomal Drug Delivery Device Market Size by Country (2020-2025) & (US$ Million)
Table 43. Latin America Liposomal Drug Delivery Device Market Size by Country (2026-2031) & (US$ Million)
Table 44. Middle East & Africa Liposomal Drug Delivery Device Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 45. Middle East & Africa Liposomal Drug Delivery Device Market Size by Country (2020-2025) & (US$ Million)
Table 46. Middle East & Africa Liposomal Drug Delivery Device Market Size by Country (2026-2031) & (US$ Million)
Table 47. Novartis AG Company Details
Table 48. Novartis AG Business Overview
Table 49. Novartis AG Liposomal Drug Delivery Device Product
Table 50. Novartis AG Revenue in Liposomal Drug Delivery Device Business (2020-2025) & (US$ Million)
Table 51. Novartis AG Recent Development
Table 52. Luye Pharma Group Company Details
Table 53. Luye Pharma Group Business Overview
Table 54. Luye Pharma Group Liposomal Drug Delivery Device Product
Table 55. Luye Pharma Group Revenue in Liposomal Drug Delivery Device Business (2020-2025) & (US$ Million)
Table 56. Luye Pharma Group Recent Development
Table 57. Ipsen Pharma Company Details
Table 58. Ipsen Pharma Business Overview
Table 59. Ipsen Pharma Liposomal Drug Delivery Device Product
Table 60. Ipsen Pharma Revenue in Liposomal Drug Delivery Device Business (2020-2025) & (US$ Million)
Table 61. Ipsen Pharma Recent Development
Table 62. Celsion, Inc. Company Details
Table 63. Celsion, Inc. Business Overview
Table 64. Celsion, Inc. Liposomal Drug Delivery Device Product
Table 65. Celsion, Inc. Revenue in Liposomal Drug Delivery Device Business (2020-2025) & (US$ Million)
Table 66. Celsion, Inc. Recent Development
Table 67. Galen Limited Company Details
Table 68. Galen Limited Business Overview
Table 69. Galen Limited Liposomal Drug Delivery Device Product
Table 70. Galen Limited Revenue in Liposomal Drug Delivery Device Business (2020-2025) & (US$ Million)
Table 71. Galen Limited Recent Development
Table 72. Astellas Pharma, Inc. Company Details
Table 73. Astellas Pharma, Inc. Business Overview
Table 74. Astellas Pharma, Inc. Liposomal Drug Delivery Device Product
Table 75. Astellas Pharma, Inc. Revenue in Liposomal Drug Delivery Device Business (2020-2025) & (US$ Million)
Table 76. Astellas Pharma, Inc. Recent Development
Table 77. Acrotech Biopharma, Inc. Company Details
Table 78. Acrotech Biopharma, Inc. Business Overview
Table 79. Acrotech Biopharma, Inc. Liposomal Drug Delivery Device Product
Table 80. Acrotech Biopharma, Inc. Revenue in Liposomal Drug Delivery Device Business (2020-2025) & (US$ Million)
Table 81. Acrotech Biopharma, Inc. Recent Development
Table 82. Fudan-Zhangjiang Company Details
Table 83. Fudan-Zhangjiang Business Overview
Table 84. Fudan-Zhangjiang Liposomal Drug Delivery Device Product
Table 85. Fudan-Zhangjiang Revenue in Liposomal Drug Delivery Device Business (2020-2025) & (US$ Million)
Table 86. Fudan-Zhangjiang Recent Development
Table 87. Pacira Company Details
Table 88. Pacira Business Overview
Table 89. Pacira Liposomal Drug Delivery Device Product
Table 90. Pacira Revenue in Liposomal Drug Delivery Device Business (2020-2025) & (US$ Million)
Table 91. Pacira Recent Development
Table 92. Creative Biolabs Company Details
Table 93. Creative Biolabs Business Overview
Table 94. Creative Biolabs Liposomal Drug Delivery Device Product
Table 95. Creative Biolabs Revenue in Liposomal Drug Delivery Device Business (2020-2025) & (US$ Million)
Table 96. Creative Biolabs Recent Development
Table 97. Precision NanoSystems Inc. Company Details
Table 98. Precision NanoSystems Inc. Business Overview
Table 99. Precision NanoSystems Inc. Liposomal Drug Delivery Device Product
Table 100. Precision NanoSystems Inc. Revenue in Liposomal Drug Delivery Device Business (2020-2025) & (US$ Million)
Table 101. Precision NanoSystems Inc. Recent Development
Table 102. Encapsula NanoSciences LLC Company Details
Table 103. Encapsula NanoSciences LLC Business Overview
Table 104. Encapsula NanoSciences LLC Liposomal Drug Delivery Device Product
Table 105. Encapsula NanoSciences LLC Revenue in Liposomal Drug Delivery Device Business (2020-2025) & (US$ Million)
Table 106. Encapsula NanoSciences LLC Recent Development
Table 107. Avanti Polar Lipids, Inc. Company Details
Table 108. Avanti Polar Lipids, Inc. Business Overview
Table 109. Avanti Polar Lipids, Inc. Liposomal Drug Delivery Device Product
Table 110. Avanti Polar Lipids, Inc. Revenue in Liposomal Drug Delivery Device Business (2020-2025) & (US$ Million)
Table 111. Avanti Polar Lipids, Inc. Recent Development
Table 112. Viatris Inc. Company Details
Table 113. Viatris Inc. Business Overview
Table 114. Viatris Inc. Liposomal Drug Delivery Device Product
Table 115. Viatris Inc. Revenue in Liposomal Drug Delivery Device Business (2020-2025) & (US$ Million)
Table 116. Viatris Inc. Recent Development
Table 117. Merrimack Pharmaceuticals, Inc Company Details
Table 118. Merrimack Pharmaceuticals, Inc Business Overview
Table 119. Merrimack Pharmaceuticals, Inc Liposomal Drug Delivery Device Product
Table 120. Merrimack Pharmaceuticals, Inc Revenue in Liposomal Drug Delivery Device Business (2020-2025) & (US$ Million)
Table 121. Merrimack Pharmaceuticals, Inc Recent Development
Table 122. Research Programs/Design for This Report
Table 123. Key Data Information from Secondary Sources
Table 124. Key Data Information from Primary Sources
Table 125. Authors List of This Report
List of Figures
Figure 1. Liposomal Drug Delivery Device Picture
Figure 2. Global Liposomal Drug Delivery Device Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Liposomal Drug Delivery Device Market Share by Type: 2024 VS 2031
Figure 4. Stealth Liposome Technology Features
Figure 5. NonPEGylated Liposome Technology Features
Figure 6. DepoFoam Liposome Technology Features
Figure 7. Global Liposomal Drug Delivery Device Market Size by Application (2020-2031) & (US$ Million)
Figure 8. Global Liposomal Drug Delivery Device Market Share by Application: 2024 VS 2031
Figure 9. Fungal Diseases Case Studies
Figure 10. Cancer Therapy Case Studies
Figure 11. Pain Management Case Studies
Figure 12. Viral Vaccines Case Studies
Figure 13. Photodynamic Therapy Case Studies
Figure 14. Liposomal Drug Delivery Device Report Years Considered
Figure 15. Global Liposomal Drug Delivery Device Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 16. Global Liposomal Drug Delivery Device Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 17. Global Liposomal Drug Delivery Device Market Share by Region: 2024 VS 2031
Figure 18. Global Liposomal Drug Delivery Device Market Share by Players in 2024
Figure 19. Global Top Liposomal Drug Delivery Device Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Liposomal Drug Delivery Device as of 2024)
Figure 20. The Top 10 and 5 Players Market Share by Liposomal Drug Delivery Device Revenue in 2024
Figure 21. North America Liposomal Drug Delivery Device Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. North America Liposomal Drug Delivery Device Market Share by Country (2020-2031)
Figure 23. United States Liposomal Drug Delivery Device Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Canada Liposomal Drug Delivery Device Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe Liposomal Drug Delivery Device Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. Europe Liposomal Drug Delivery Device Market Share by Country (2020-2031)
Figure 27. Germany Liposomal Drug Delivery Device Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. France Liposomal Drug Delivery Device Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. U.K. Liposomal Drug Delivery Device Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Italy Liposomal Drug Delivery Device Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Russia Liposomal Drug Delivery Device Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Nordic Countries Liposomal Drug Delivery Device Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific Liposomal Drug Delivery Device Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Asia-Pacific Liposomal Drug Delivery Device Market Share by Region (2020-2031)
Figure 35. China Liposomal Drug Delivery Device Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Japan Liposomal Drug Delivery Device Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. South Korea Liposomal Drug Delivery Device Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Southeast Asia Liposomal Drug Delivery Device Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. India Liposomal Drug Delivery Device Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Australia Liposomal Drug Delivery Device Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America Liposomal Drug Delivery Device Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Latin America Liposomal Drug Delivery Device Market Share by Country (2020-2031)
Figure 43. Mexico Liposomal Drug Delivery Device Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Brazil Liposomal Drug Delivery Device Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa Liposomal Drug Delivery Device Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Middle East & Africa Liposomal Drug Delivery Device Market Share by Country (2020-2031)
Figure 47. Turkey Liposomal Drug Delivery Device Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Saudi Arabia Liposomal Drug Delivery Device Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. UAE Liposomal Drug Delivery Device Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 50. Novartis AG Revenue Growth Rate in Liposomal Drug Delivery Device Business (2020-2025)
Figure 51. Luye Pharma Group Revenue Growth Rate in Liposomal Drug Delivery Device Business (2020-2025)
Figure 52. Ipsen Pharma Revenue Growth Rate in Liposomal Drug Delivery Device Business (2020-2025)
Figure 53. Celsion, Inc. Revenue Growth Rate in Liposomal Drug Delivery Device Business (2020-2025)
Figure 54. Galen Limited Revenue Growth Rate in Liposomal Drug Delivery Device Business (2020-2025)
Figure 55. Astellas Pharma, Inc. Revenue Growth Rate in Liposomal Drug Delivery Device Business (2020-2025)
Figure 56. Acrotech Biopharma, Inc. Revenue Growth Rate in Liposomal Drug Delivery Device Business (2020-2025)
Figure 57. Fudan-Zhangjiang Revenue Growth Rate in Liposomal Drug Delivery Device Business (2020-2025)
Figure 58. Pacira Revenue Growth Rate in Liposomal Drug Delivery Device Business (2020-2025)
Figure 59. Creative Biolabs Revenue Growth Rate in Liposomal Drug Delivery Device Business (2020-2025)
Figure 60. Precision NanoSystems Inc. Revenue Growth Rate in Liposomal Drug Delivery Device Business (2020-2025)
Figure 61. Encapsula NanoSciences LLC Revenue Growth Rate in Liposomal Drug Delivery Device Business (2020-2025)
Figure 62. Avanti Polar Lipids, Inc. Revenue Growth Rate in Liposomal Drug Delivery Device Business (2020-2025)
Figure 63. Viatris Inc. Revenue Growth Rate in Liposomal Drug Delivery Device Business (2020-2025)
Figure 64. Merrimack Pharmaceuticals, Inc Revenue Growth Rate in Liposomal Drug Delivery Device Business (2020-2025)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Household Embroidery Machines Market Research Report 2025
Jul 18, 25
Global Residential Electric Underfloor Heating Market Research Report 2025
Jul 18, 25
Global Commercial Electric Underfloor Heating Market Research Report 2025
Jul 18, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232